FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)

View source ↗

Summary

The FDA approved a supplemental NDA for Cardizem CD (diltiazem hydrochloride) submitted by Bausch Health US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Atrial Fibrillation
• Atrial Flutter
• Hypertension
• Supraventricular Tachycardia

Drugs mentioned

• Cardizem CD (Diltiazem hydrochloride)

Snippet

SUPPL AP for CARDIZEM CD (DILTIAZEM HYDROCHLORIDE)